The Bateman lab investigates the causes and methods of diagnosis and treatment of Alzheimer’s disease (AD), utilizing a wide variety of assays and techniques from basic applications, such as quantitative measurement of stable-isotope labeled peptides to clinical translational studies of diagnostic and therapeutic biomarkers for AD.